Reuters logo
BRIEF-Merck says numerical increase in atrial fibrillation and stroke seen in patients taking osteoporosis drug odanacatib
May 6, 2014 / 1:55 PM / 3 years ago

BRIEF-Merck says numerical increase in atrial fibrillation and stroke seen in patients taking osteoporosis drug odanacatib

May 6 (Reuters) - Merck & Co Inc : * Says numerical increase in risk of atrial fibrillation and stroke seen in

patients taking osteoporosis drug odanacatib in late-stage trials * Says “no imbalance” seen in incidence of major cardiovascular events among patients

taking odanacatib and placebo group * Says skin thickening, itching condition seen in 0.2 percent of patients

taking odanacatib * Says 0.1 percent of patients taking odanacatib had femoral shaft fractures,

more than in placebo group

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below